Indivior Pharmaceuticals
INDV
INDV
197 hedge funds and large institutions have $2.68B invested in Indivior Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 52 increasing their positions, 42 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
24% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 42
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
85.73% less ownership
Funds ownership: 85.73% → 0% (-86%)
Holders
197
Holding in Top 10
10
Calls
$57M
Puts
$1.12M
Top Buyers
| 1 | +$5.16B | |
| 2 | +$106M | |
| 3 | +$67.5M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$66.3M |
| 5 |
BlackRock
New York
|
+$63.7M |
Top Sellers
| 1 | -$74.9M | |
| 2 | -$73.6M | |
| 3 | -$62.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$45.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$33.4M |
